Edikan A. Ogunnaike

935 total citations · 2 hit papers
13 papers, 793 citations indexed

About

Edikan A. Ogunnaike is a scholar working on Oncology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Edikan A. Ogunnaike has authored 13 papers receiving a total of 793 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Biomedical Engineering. Recurrent topics in Edikan A. Ogunnaike's work include CAR-T cell therapy research (9 papers), Immunotherapy and Immune Responses (4 papers) and Nanowire Synthesis and Applications (4 papers). Edikan A. Ogunnaike is often cited by papers focused on CAR-T cell therapy research (9 papers), Immunotherapy and Immune Responses (4 papers) and Nanowire Synthesis and Applications (4 papers). Edikan A. Ogunnaike collaborates with scholars based in United States, China and France. Edikan A. Ogunnaike's co-authors include Gianpietro Dotti, Frances S. Ligler, Sarah Ahn, Zhen Gu, Quanyin Hu, Guojun Chen, Chao Wang, Qian Chen, Elena Dukhovlinova and Yevgeny Brudno and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Advanced Materials.

In The Last Decade

Edikan A. Ogunnaike

11 papers receiving 785 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Photothermal Therapy Promotes Tumor Infiltration and Antitumor Activity of CAR T Cells

2019 400 citations Qian Chen, Quanyin Hu et al. Advanced Materials profile →
Bioinstructive implantable scaffolds for rapid in vivo manufacture and release of CAR-T cells

2022 138 citations Edikan A. Ogunnaike, Sarah Ahn et al. Nature Biotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edikan A. Ogunnaike United States	8	513	362	285	235	121	13	793
Dimitrios C. Arhontoulis United States	6	320 0.6×	305 0.8×	218 0.8×	227 1.0×	259 2.1×	9	777
Sarah Ahn United States	11	786 1.5×	796 2.2×	514 1.8×	408 1.7×	175 1.4×	15	1.4k
Andrew Satterlee United States	13	425 0.8×	200 0.6×	161 0.6×	628 2.7×	369 3.0×	29	1.2k
Huizi Sha China	17	309 0.6×	401 1.1×	277 1.0×	577 2.5×	245 2.0×	41	1.1k
Elise Robinson United States	10	377 0.7×	117 0.3×	134 0.5×	514 2.2×	161 1.3×	22	891
Huapan Fang China	19	498 1.0×	126 0.3×	255 0.9×	448 1.9×	266 2.2×	43	1.1k
Kelly R. Rhodes United States	12	266 0.5×	125 0.3×	204 0.7×	303 1.3×	109 0.9×	21	723
Ragy Ragheb United States	7	391 0.8×	260 0.7×	374 1.3×	286 1.2×	234 1.9×	7	823
Maxence O. Dellacherie United States	12	513 1.0×	340 0.9×	603 2.1×	426 1.8×	150 1.2×	13	1.1k
Pingjie Sun China	12	435 0.8×	136 0.4×	209 0.7×	337 1.4×	172 1.4×	13	760

Countries citing papers authored by Edikan A. Ogunnaike

Since Specialization

Citations

This map shows the geographic impact of Edikan A. Ogunnaike's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edikan A. Ogunnaike with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edikan A. Ogunnaike more than expected).

Fields of papers citing papers by Edikan A. Ogunnaike

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edikan A. Ogunnaike. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edikan A. Ogunnaike. The network helps show where Edikan A. Ogunnaike may publish in the future.

Co-authorship network of co-authors of Edikan A. Ogunnaike

This figure shows the co-authorship network connecting the top 25 collaborators of Edikan A. Ogunnaike. A scholar is included among the top collaborators of Edikan A. Ogunnaike based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edikan A. Ogunnaike. Edikan A. Ogunnaike is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Wang, Yixin, Edikan A. Ogunnaike, Huan Yang, et al.. (2025). Platelet-engineered CAR-T cells as adjuvant therapy after cancer surgery. Proceedings of the National Academy of Sciences. 122(51). e2522020122–e2522020122.

Yang, Ruiyue, Yuhang Yao, Fan Jiang, et al.. (2025). In Situ PROTAC Synthesis Enabled by Pathologically Activated Bioorthogonal Catalysis for Precision Cancer Therapy. Journal of the American Chemical Society. 147(43). 39987–39998.

Attia, Mohamed F., Edikan A. Ogunnaike, Nancy M. Elbaz, et al.. (2023). Enhancing drug delivery with supramolecular amphiphilic macrocycle nanoparticles: selective targeting of CDK4/6 inhibitor palbociclib to melanoma. Biomaterials Science. 12(3). 725–737. 1 indexed citations

Landoni, Elisa, et al.. (2023). Utilizing induced neural stem cell‐based delivery of a cytokine cocktail to enhance chimeric antigen receptor‐modified T‐cell therapy for brain cancer. Bioengineering & Translational Medicine. 8(6). e10538–e10538. 4 indexed citations

Xu, Fang, Jialu Xu, Huaxing Dai, et al.. (2023). Engineering of dendritic cell bispecific extracellular vesicles for tumor-targeting immunotherapy. Cell Reports. 42(10). 113138–113138. 20 indexed citations

Ogunnaike, Edikan A., Sarah Ahn, Anton Jansson, et al.. (2022). Bioinstructive implantable scaffolds for rapid in vivo manufacture and release of CAR-T cells. Nature Biotechnology. 40(8). 1250–1258. 138 indexed citations breakdown →

Sun, Jian, Edikan A. Ogunnaike, Xing Jiang, & Zhaowei Chen. (2021). Nanotechnology lights up the antitumor potency by combining chemotherapy with siRNA. Journal of Materials Chemistry B. 9(36). 7302–7317. 9 indexed citations

Chu, Jiacheng, Chenya Wang, Qingle Ma, et al.. (2021). Coupling programmed cell death 1-positive tumor-infiltrating T cells with anti-programmed cell death 1 antibody improves the efficacy of adoptive T-cell therapy. Cytotherapy. 24(3). 291–301. 3 indexed citations

Ogunnaike, Edikan A., Mostafa Yazdimamaghani, Seema Nandi, et al.. (2021). Fibrin gel enhances the antitumor effects of chimeric antigen receptor T cells in glioblastoma. Science Advances. 7(41). eabg5841–eabg5841. 68 indexed citations

10.

Li, Hongjun, Zejun Wang, Edikan A. Ogunnaike, et al.. (2021). Scattered seeding of CAR T cells in solid tumors augments anticancer efficacy. National Science Review. 9(3). nwab172–nwab172. 106 indexed citations

11.

Ogunnaike, Edikan A., et al.. (2020). Scaffold‐Mediated Static Transduction of T Cells for CAR‐T Cell Therapy. Advanced Healthcare Materials. 9(14). e2000275–e2000275. 19 indexed citations

12.

Chen, Qian, Quanyin Hu, Elena Dukhovlinova, et al.. (2019). Photothermal Therapy: Photothermal Therapy Promotes Tumor Infiltration and Antitumor Activity of CAR T Cells (Adv. Mater. 23/2019). Advanced Materials. 31(23). 25 indexed citations

13.

Chen, Qian, Quanyin Hu, Elena Dukhovlinova, et al.. (2019). Photothermal Therapy Promotes Tumor Infiltration and Antitumor Activity of CAR T Cells. Advanced Materials. 31(23). e1900192–e1900192. 400 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact